Table 2 Clinical characteristics of the study subjects with hypertension
Parameter | HToccp | HTmulti | HTcomb |
|---|---|---|---|
Number | 1019 | 817 | 1836 |
Age (years) | 50 ± 9 | 62 ± 9* | 55 ± 11 |
Gender (male/female) | 963/56 | 444/373* | 1407/429 |
BMI (kg/m2) | 25.5 ± 3.6 | 24.6 ± 3.6* | 25.1 ± 3.6 |
Smoking (current) (%) | 313 (31) | 93 (11)* | 406 (22.1) |
SBP (mm Hg) | 140 ± 14 | 134 ± 14* | 137 ± 14 |
DBP (mm Hg) | 87 ± 11 | 80 ± 10* | 84 ± 11 |
Heart rate (beats/min) | 69 ± 10 | 72 ± 12* | 70 ± 11 |
baPWV (cm/s) | 1483 ± 233 | 1619 ± 309* | 1543 ± 275 |
baPWV ≥1600cm/s (%) | 272 (26.7) | 383 (46.9)* | 655 (35.7) |
baPWV ≥1800 cm/s (%) | 102 (10.0) | 186 (22.8)* | 288 (15.7) |
TC (mmol/L) | 5.5 ± 0.9 | 5.2 ± 0.9* | 5.4 ± 0.9 |
HDL (mmol/L) | 1.6 ± 0.4 | 1.5 ± 0.4 | 1.6 ± 0.4 |
FBS (mmol/L) | 5.4 ± 1.1 | 5.8 ± 1.1* | 5.6 ± 1.1 |
Crnn (μmol/L) | 75 ± 13 | 67 ± 18* | 71 ± 16 |
SAGE score | 4.0 ± 2.4 | 5.9 ± 2.7* | 4.8 ± 2.7 |
Medications | |||
Receiving medication for hypertension (%) | 755 (74.0) | 817 (100)* | 1572 (85.6) |
Receiving medication for dyslipidemia (%) | 195 (19.2) | 225 (27.5)* | 420 (22.9) |
Receiving medication for diabetes mellitus (%) | 131 (12.9) | 72 (8.6)* | 204 (11.1) |